Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Recognition of nonproline N-terminal residues by the Pro/N-degron pathway

View ORCID ProfileCheng Dong, View ORCID ProfileShun-Jia Chen, Artem Melnykov, Sara Weirich, Kelly Sun, Albert Jeltsch, Alexander Varshavsky, and Jinrong Min
PNAS June 23, 2020 117 (25) 14158-14167; first published June 8, 2020; https://doi.org/10.1073/pnas.2007085117
Cheng Dong
aDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, 300070 Tianjin, People’s Republic of China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cheng Dong
Shun-Jia Chen
bDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shun-Jia Chen
Artem Melnykov
cAuragent Bioscience, St. Louis, MO 63108;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Weirich
dDepartment of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University Stuttgart, 70569 Stuttgart, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Sun
eStructural Genomics Consortium, Department of Physiology, University of Toronto, Toronto, ON M5G 1L7, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Jeltsch
dDepartment of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University Stuttgart, 70569 Stuttgart, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Varshavsky
bDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: avarsh@caltech.edu jr.min@utoronto.ca
Jinrong Min
eStructural Genomics Consortium, Department of Physiology, University of Toronto, Toronto, ON M5G 1L7, Canada;
fHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, 430079 Wuhan, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: avarsh@caltech.edu jr.min@utoronto.ca
  1. Edited by F. Ulrich Hartl, Max Planck Institute of Chemistry, Martinsried, Germany, and approved May 13, 2020 (received for review April 14, 2020)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

The Pro/N-degron pathway targets proteins for degradation through their N-terminal (Nt) proline (Pro) residue. GID4, a subunit of the GID ubiquitin ligase, is the recognition component of the Pro/N-degron pathway. Here we show that human GID4 can also recognize hydrophobic Nt-residues other than Pro. In agreement with these results, a protein bearing the Nt-sequence IGLW was found to be targeted for degradation by the yeast Pro/N-degron pathway. We solved crystal structures of human GID4 bound to specific peptides, and explored the roles of GID4 residues in the targeting of its substrates. These and related results advance the understanding of the Pro/N-degron pathway and expand the substrate recognition range of the GID ubiquitin ligase in both human and yeast cells.

Abstract

Eukaryotic N-degron pathways are proteolytic systems whose unifying feature is their ability to recognize proteins containing N-terminal (Nt) degradation signals called N-degrons, and to target these proteins for degradation by the 26S proteasome or autophagy. GID4, a subunit of the GID ubiquitin ligase, is the main recognition component of the proline (Pro)/N-degron pathway. GID4 targets proteins through their Nt-Pro residue or a Pro at position 2, in the presence of specific downstream sequence motifs. Here we show that human GID4 can also recognize hydrophobic Nt-residues other than Pro. One example is the sequence Nt-IGLW, bearing Nt-Ile. Nt-IGLW binds to wild-type human GID4 with a Kd of 16 μM, whereas the otherwise identical Nt-Pro–bearing sequence PGLW binds to GID4 more tightly, with a Kd of 1.9 μM. Despite this difference in affinities of GID4 for Nt-IGLW vs. Nt-PGLW, we found that the GID4-mediated Pro/N-degron pathway of the yeast Saccharomyces cerevisiae can target an Nt-IGLW–bearing protein for rapid degradation. We solved crystal structures of human GID4 bound to a peptide bearing Nt-Ile or Nt-Val. We also altered specific residues of human GID4 and measured the affinities of resulting mutant GID4s for Nt-IGLW and Nt-PGLW, thereby determining relative contributions of specific GID4 residues to the GID4-mediated recognition of Nt-Pro vs. Nt-residues other than Pro. These and related results advance the understanding of targeting by the Pro/N-degron pathway and greatly expand the substrate recognition range of the GID ubiquitin ligase in both human and yeast cells.

  • degron
  • GID
  • GID4
  • ubiquitin
  • degradation

Regulated protein degradation protects cells from misfolded, aggregated, and otherwise abnormal proteins, and also controls the levels of proteins that evolved to be short-lived in vivo. One function of protein degradation is the quality control of nascent and newly formed proteins. Selective proteolysis eliminates proteins (including mutant ones) that fold too slowly, misfold, or do not satisfy other requirements of quality control. The intracellular protein degradation is mediated largely by the ubiquitin (Ub)-proteasome system and autophagy-lysosome pathways, with molecular chaperones being a part of both systems (1⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–18).

The ubiquitin (Ub)-proteasome system comprises pathways that have in common at least two classes of enzymes, E3-E2 Ub ligases and deubiquitylases (DUBs). A Ub ligase recognizes a substrate protein through its degradation signal (degron) and conjugates Ub, a 9-kDa protein (usually in the form of a poly-Ub chain), to an amino acid residue (usually an internal lysine) of a targeted substrate. The functions of DUBs include deubiquitylation of Ub-conjugated proteins (2, 5, 10, 12, 19⇓⇓⇓⇓–24). The 26S proteasome, a multisubunit ATP-dependent protease, binds to a ubiquitylated protein substrate through a substrate-linked poly-Ub chain, unfolds the protein using proteasomal ATPases (often with involvement of the Cdc48/p97 unfoldase), and processively destroys the protein to ∼10-residue peptides (25⇓⇓⇓⇓⇓⇓–32).

N-degron pathways (previously called “N-end rule pathways”) are a set of proteolytic systems whose unifying feature is their ability to recognize proteins containing N-terminal (Nt) degradation signals called N-degrons, thereby causing the degradation of these proteins by the 26S proteasome or autophagy in eukaryotes, and by the proteasome-like ClpAP protease in bacteria (2, 22, 33⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–74). N-degron pathways are Ub-dependent in eukaryotes but not in bacteria. The main determinants of an N-degron include a destabilizing Nt-residue of a protein substrate and an internal Lys residue (or residues) that acts as the site of polyubiquitylation (2, 34).

Initially, most N-degrons are pro–N-degrons. They are converted to active N-degrons either constitutively (e.g., cotranslationally) or conditionally, via regulated steps. Among the routes to N-degrons are cleavages of proteins by proteases that include Met-aminopeptidases (MetAPs), caspases, and calpains. These and many other nonprocessive proteases function as initial targeting components of N-degron pathways by cleaving a prosubstrate protein and exposing a destabilizing Nt-residue in the resulting C-terminal (Ct) fragment (37, 57, 69, 70, 74⇓⇓⇓⇓⇓–80).

A different and mutually nonexclusive route to N-degrons is through enzymatic Nt-modifications of proteins, including Nt-acetylation, Nt-deamidation, Nt-arginylation, Nt-leucylation, or Nt-formylation of Nt-residues. Recognition components of N-degron pathways, called N-recognins, are E3 Ub ligases or other proteins (e.g., bacterial ClpS or mammalian p62) that can target specific N-degrons (2, 15, 38). In cognate sequence contexts, all 20 amino acids of the genetic code can act as destabilizing Nt-residues (2). Consequently, a number of cellular proteins and their natural Ct-fragments are either constitutively or conditionally short-lived N-degron substrates. Some N-recognin E3s are able to recognize, through distinct binding sites, not only N-degrons but also specific non–N-terminal degradation signals, thereby further expanding the substrate range of N-degron pathways (2, 39).

Eukaryotic N-degron pathways comprise the Arg/N-degron pathway (it recognizes, in particular, specific unacetylated Nt-residues); the Ac/N-degron pathway (it recognizes, in particular, the Nα-terminally acetylated [Nt-acetylated] Nt-residues); the fMet/N-degron pathway (it recognizes Nt-formylated proteins); and the Pro/N-degron pathway (it recognizes, in particular, the Nt-proline [Pro] residue or a Pro at position 2, in the presence of cognate adjoining sequence motifs) (2, 35, 38⇓⇓⇓–42, 74). The latter pathway is the main subject of this report (Fig. 1).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

The S. cerevisiae Pro/N-degron pathway. The diagram shows both GID4, the pathway’s main N-recognin, and GID10, a stress-inducible and functionally minor N-recognin (see Introduction and references therein). Findings of the present study demonstrated, in particular, the ability of both human and S. cerevisiae GID4 to recognize, in peptide-sized polypeptides bearing cognate adjoining motifs, not only Nt-Pro but also Nt-Ile, Nt-Leu, Nt-Val, and Nt-Phe. In addition, the S. cerevisiae Pro/N-degron pathway was found to target a test protein bearing the Nt-Ile–containing sequence IGLW for rapid degradation that required GID4 (Results).

Regulated degradation of proteins and their natural fragments by N-degron pathways has been shown to mediate a multitude of processes, including the sensing of heme, oxygen, and nitric oxide; the control of subunit stoichiometries in protein complexes; selective elimination of misfolded proteins and of proteins retrotranslocated to the cytosol from other compartments; repression of neurodegeneration and regulation of either apoptosis or other pathways of programmed cell death; regulation of DNA repair, transcription, replication, and chromosome cohesion/segregation; regulation of chaperones, G proteins, cytoskeletal proteins, autophagy, gluconeogenesis, peptide import, meiosis, circadian rhythms, fat metabolism, cell migration, immunity (including inflammation), cardiovascular system, spermatogenesis, and neurogenesis; and regulation of many processes in plants (refs. 2, 22, 35, 37⇓⇓⇓⇓⇓⇓⇓–45, 49⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–74, and 81 and references therein).

To keep notations uniform, human genetic terms (all-uppercase letters) are used below to denote both human and yeast (Saccharomyces cerevisiae) genes and proteins. Under conditions of low or absent glucose, cells can synthesize it through gluconeogenesis. In S. cerevisiae, the main gluconeogenesis-specific cytosolic enzymes are the FBP1 fructose-1,6-bisphosphatase, the ICL1 isocitrate lyase, the MDH2 malate dehydrogenase, and the PCK1 phosphoenolpyruvate carboxykinase (43, 74, 82⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–95). When S. cerevisiae grows on a nonfermentable carbon source such as, for example, ethanol, gluconeogenic enzymes are expressed and long-lived. A shift to a medium containing glucose inhibits the synthesis of these enzymes and induces their degradation. Degradation of yeast gluconeogenic enzymes requires the multisubunit GID Ub ligase (74, 86, 87, 90, 96, 97). The ∼600-kDa GID comprises at least the GID1, GID2, GID4, GID5, GID7, GID8, GID9, and GID10 subunits, as well as the weakly associated Ub-conjugating (E2) enzyme UBC8 (GID3) (43, 44, 46, 47, 86, 96). GID10 is expressed only during some stresses (47).

A notable aspect of GID-mediated processes is the dichotomy between the GID/proteasome-mediated degradation of gluconeogenic enzymes and their “alternative” degradation through an autophagy-related pathway called vacuolar import and degradation (VID) (87, 90, 93, 95, 98⇓–100). The VID pathway may also involve a GID-mediated polyubiquitylation of gluconeogenic enzymes. Whether these enzymes are destroyed (after a return of cells to glucose-containing media) largely by the GID/proteasome pathway or largely by the VID pathway depends, among other things, on the duration of glucose starvation and the nature of a nonglucose carbon source (84, 101). The function of this dichotomy, the regulation of transitions between the GID/proteasome and VID pathways, and molecular mechanisms of VID remain to be understood (43, 96).

S. cerevisiae GID4 is a 41-kDa subunit of GID (43, 44, 97). Chen et al. and Melnikov et al. have shown that GID4 and (stress-inducible) GID10 are N-recognin subunits of the GID Ub ligase that mediates the Pro/N-degron pathway (Fig. 1) (2, 43⇓⇓⇓–47). GID4, the main N-recognin of this pathway, binds to protein substrates through their Nt-Pro residue or a Pro at position 2 in the also required presence of adjoining sequence motifs (43⇓⇓–46). S. cerevisiae gluconeogenic enzymes bear either Nt-Pro (FBP1, ICL1, MDH2) or a Pro at position 2 (PCK1). These enzymes are conditionally short-lived substrates of the Pro/N-degron pathway (Fig. 1) (43, 45, 97). Dong et al. (44) determined the crystal structure of human GID4, which comprises an antiparallel β-barrel that contains a substrate-binding cleft (44⇓–46). Qiao et al. (46) employed cryoelectron microscopy and other methods to characterize the entire GID Ub ligase, revealing its overall shape and also, in particular, specific interactions between its N-recognin subunit GID4 and the rest of GID. In mammals, the GID Ub ligase (it is also called CTLH) functions in primary cilia, in cell proliferation, and in other processes (96, 102⇓⇓⇓⇓⇓⇓⇓–110).

Here we show that human GID4 (in the presence of cognate downstream motifs) can recognize not only the Nt-Pro residue but other specific hydrophobic Nt-residues as well. We solved crystal structures of human GID4 bound to a peptide bearing either Nt-Ile or Nt-Val. We also used site-directed mutagenesis of GID4 to analyze the roles of GID4 residues in the binding of substrates by this N-recognin. These approaches determined relative contributions of specific GID4 residues to the GID4-mediated recognition of Nt-Pro versus Nt-residues other than Pro. We also show that S. cerevisiae GID4 can target a protein bearing a Pro-lacking Nt-sequence, such as Nt-IGLW, for rapid degradation by the Pro/N-degron pathway. These and related results advanced the understanding of GID4 N-recognin and expanded the substrate recognition range of the Pro/N-degron pathway in both human and yeast cells.

Results and Discussion

GID4 Can Recognize Nt-Sequence Motifs Lacking Pro.

GID4, a subunit of the GID Ub ligase and the main N-recognin of the Pro/N-degron pathway, has been shown to recognize (specifically bind to), both in vitro and in vivo, protein substrates that contain the Nt-Pro residue or a Pro at position 2, in the also required presence of cognate adjoining sequence motifs (Fig. 1) (43⇓–45). For example, in vivo yeast-based two-hybrid (Y2H) binding assays could detect the binding of S. cerevisiae GID4 to the Nt-Pro–bearing gluconeogenic enzyme Pro-FBP1 but not to its otherwise identical Nt-Ser–bearing mutant Ser-FBP1 (43). This recognition specificity of GID4 underlied the GID4-dependent in vivo degradation of Pro-FBP1, in contrast to metabolic stability of Ser-FBP1 (43). Yeast GID4 was also found to bind, in Y2H assays, to the Nt-sequence SPSV, which contained a Pro at position 2. That Nt-sequence was identical to the Nt-sequence SPSK of the short-lived S. cerevisiae gluconeogenic enzyme PCK1 (an in vivo substrate of GID4), save for the presence of Val, instead of Lys, at position 4 of SPSV (43).

Crystal structures of human GID4 bound to different Nt-Pro–containing short peptides showed that the main-chain α-imino group of Nt-Pro in these peptides is coordinated by five GID4-mediated hydrogen bonds, while the pyrrolidine side chain of Pro is bound to a hydrophobic patch in GID4 (44). It seemed possible that the pyrrolidine-contacting hydrophobic pocket of GID4 might tolerate some hydrophobic residues other than Pro. To address this conjecture, we used a mutation-scanning peptide SPOT array to characterize the substrate specificity of human GID4. Each residue of the PGLVKSAS peptide was substituted, systematically, with 1 of 18 amino acids of the genetic code, save for Cys and Trp, because of difficulties in using the latter residues to synthesize SPOT peptides. The array was incubated with full-length human GID4 N-terminally tagged with glutathione transferase (GST), and the binding of GID4 to peptide spots was detected using antibody to GST and chemilumenescence (Fig. 2).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Use of peptide arrays to analyze substrate recognition by human GID4. (A) Binding patterns of the full-length human GID4 to an array of the spotted Nt-Pro–bearing peptide PGLVKASAS (top row, denoted “wild-type” [wt]) and its indicated derivatives (Materials and Methods). (B) The array binding data were quantified and the relative binding of GID4 to each peptide is shown, with strong to weak binding scaled from black to white. (C) These substrate preferences of GID4 are also shown as a sequence logo.

We found that several hydrophobic residues (Ile, Leu, Val, and Phe) could substitute for Nt-Pro in the above SPOT sequence without eliminating the binding of resulting peptides to human GID4 (Fig. 2). In agreement with previous evidence (44), the binding of GID4 was stronger if a small side-chain residue was present at position 2. In addition, no significant binding of GID4 was observed with peptides bearing Gly, Asp, or Pro at position 3. GID4 exhibited at most a minor dependence of its binding to array’s peptides beyond position 3 (Fig. 2).

To further analyze these binding patterns, we synthesized a set of six-residue peptides (XGLWKS; X = any Nt-residue), and used an isothermal titration calorimetry (ITC) binding assay to quantify their interactions with the binding-competent GID4116−300 fragment of the full-length human GID41−300 (44) (Fig. 3). Since the binding of XGLVKSAS peptides by GID4 did not exhibit a significant sequence specificity beyond position 3 (Fig. 2), the four-residue XGLW was extended by the Lys-Ser (KS) Ct-sequence to increase solubility of peptides that were used in ITC binding assays.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Affinities (Kds) of XGLWKS peptides for the GID4116–300 fragment of the full-length human GID41–300 (44). NDB, no detectable binding to GID4116–300 (Kd > 0.5 mM). Superscript “a” (a) signifies ITC measurements with CGLWKS performed using a cysteine-deficient mutant of GID4116–300 (Materials and Methods and SI Appendix, Fig. S2).

In agreement with SPOT-array data (Fig. 2), GID4116−300 exhibited significant affinities for the XGLWKS peptides in which X was either Ile (Kd of 16 μM), Leu (Kd of 21 μM), Val (Kd of 36 μM), or Phe (Kd of 40 μM). The affinity of GID4116−300 for the otherwise identical but Nt-Pro–bearing PGLWKS (Kd of 1.9 μM) was still significantly stronger than for the other four peptides (Fig. 3 and SI Appendix, Fig. S1). While the binding of GID4116−300 to the Nt-Met–bearing sequence MGLWKS could still be detected by ITC, the binding affinity (Kd of 72 μM) was even lower than the affinity of GID4116−300 for the FGLWKS peptide (Figs. 1 and 3 and SI Appendix, Fig. S1).

Unexpectedly, we found that GID4116−300 had a relatively high affinity (Kd of 7 μM) for the Nt-Cys–bearing CGLWKS peptide (SI Appendix, Fig. S2A). Inasmuch as there was no detectable binding of GID4116−300 to the SGLWKS peptide, whose Nt-Ser is sterically and chemically similar to Nt-Cys (Fig. 3), we suspected that the binding to CGLWKS may have been artifactually strengthened by the formation of a disulfide bond between Nt-Cys of CGLWKS and a Cys residue of GID4116−300. In the 3D crystal structure of GID4 (44), one of two Cys solvent-exposed residues, Cys-156 and Cys-261, might be involved in the disulfide bond formation with Nt-Cys of CGLWKS (SI Appendix, Fig. S2 D–F). To address this possibility, we constructed a human GID4116−300 mutant in which these two cysteines were converted to Ser. In agreement with our assumption, the GID4116−300, C156S, C261S mutant retained a nearly wild-type (high) affinity for the Nt-Pro–bearing PGLWKS peptide but did not exhibit a detectable binding to the CGLWKS peptide (SI Appendix, Fig. S2). In sum and for the reasons above, an Nt-Cys–bearing polypeptide is unlikely to be a physiologically relevant GID4 ligand.

Structural Basis for the Binding of Human GID4 to Non-Pro Nt-Residues.

To address molecular basis of the GID4-mediated recognition of Nt-sequences that bear non-Pro Nt-residues, we determined high-resolution crystal structures of human GID4124−289 in complexes with the six-residue peptides IGLWKS and VGLWKS, respectively (Figs. 4 and 5A; see SI Appendix, Table S1 for crystal diffraction data and model refinement statistics). Detailed comparisons showed that the structures of GID4124−289-IGLWKS and GID4124−289-VGLWKS are very similar to that of GID4124−289-PGLWKS, with backbone RMSDs of less than 0.5 Å (Fig. 4).

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Structural basis of recognition of nonproline N-terminal residues by human GID4. (A) Superposition, in ribbon diagrams, of the overall crystal structures of complexes of GID4124–289 with, respectively, PGLWKS (salmon, PDB ID code 6CDG), VGLWKS (green), and IGLWKS (cyan) peptides (see also Materials and Methods and SI Appendix, Table S1). (B) Close-up view of similar (conserved) interactions between the substrate-binding chamber of GID4 and the first four residues of the above peptides (PGLW, salmon; VGLW, green; and IGLW, cyan). The most relevant residues of GID4 are shown as gray/red/blue sticks vis-à-vis colored peptides. Hydrogen bonds are indicated as black dash lines. (C) Close-up view of the recognition of the Nt-Ile–bearing IGLWKS peptide in the substrate-binding chamber of human GID4. Denoted in red are the first four residues of the six-residue peptide. These residues are depicted as cyan/red/blue sticks. The most relevant residues of the GID4 chamber are either in black or in green (the hydrophilic Thr-173 residue), and are depicted via surface representations and gray sticks.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

(A) Plot of affinities (relative association constants, Kas) of the Nt-Ile–bearing peptide IGLWKS for GID4116–300 and its indicated single-residue mutants, with the affinity of wild-type GID4116–300 for IGLWKS taken as 100%. NDB, no detectable binding (Kd > 0.5 mM). (B) Plot of affinities (relative association constants, Kas) of the Nt-Ile–bearing peptide IGLWKS for GID4116–300 and its indicated position-173 mutants, with the affinity of wild-type GID4116–300 for IGLWKS taken as 100%. (C) Plot of affinities (relative association constants, Kas) of the Nt-Pro–bearing peptide PGLWKS for GID4116–300 and its indicated position-173 mutants, with the affinity of wild-type GID4116–300 for PGLWKS taken as 100%. In B and C, the highest-affinity levels for position-173 GID4 mutants (they differ for the IGLWKS versus PGLWKS peptides) are highlighted in red.

The α-amino groups of the above non–Nt-Pro peptides are coordinated by a set of conserved hydrogen bonds, similar to the set that coordinates the Nt–α-imino group of the Nt-Pro peptide. Specifically, the free α-amino group of Nt–Val-1 or Nt–Ile-1 forms hydrogen bonds with the side chains of Glu-237 and Tyr-258 of GID4, while the carbonyl oxygen of Val-1 or Ile-1 is further stabilized, through another hydrogen bond, by Gln-132 of GID4. The main chain of the second residue (Gly-2) of the six-residue peptides is anchored by the main chain of Ser-253 via two hydrogen bonds. The main chain of the third residue (Leu-3) of a bound peptide forms two hydrogen bonds with the side chain of Gln-282. Trp-4, the fourth residue of these peptides, interacts, through a hydrogen bond, with Gly-251 of GID4 (Figs. 4 and 5A). Inasmuch as bound peptides are located in the nearly enclosed binding channel of GID4, and since the first (Nt) residue of a peptide is deeply buried in the channel’s narrow end, the Pro residue is preferred, affinity-wise, as the Nt-residue of a GID4 substrate. But the binding cavity is still large enough to accommodate some other hydrophobic residues, such as Ile or Val. In this cavity of GID4, the side chain of a peptide’s Nt-residue is surrounded by the hydrophobic residues L159, V141, I161, L164, L171, I249, L240, and F254 (Figs. 4 and 5A).

Use of GID4 Mutants to Analyze Binding Specificity of GID4.

We used site-directed mutagenesis to convert to Ala residues – specific bulky hydrophobic residues of GID4 that surround the Nt-Ile residue of the GID4-bound IGLWKS peptide. These single-residue mutations caused a strong reduction of binding of the IGLWKS peptide to a mutant GID4, or even the loss of detectable binding (Fig. 5B and SI Appendix, Table S2).

Interestingly, an uncharged hydrophilic residue of GID4, Thr-173, is located near the hydrophobic pocket that binds to a hydrophobic Nt-residue of a substrate (Fig. 5A). Because of its spatial proximity to the hydrophobic pocket, Thr-173 might interfere with the binding of Nt-Pro or other substrates’ hydrophobic Nt-residues to wild-type GID4. To address this possibility, Thr-173 of GID4 was replaced with single hydrophobic residues, such as Ala, Val, Leu, and Ile. In agreement with the above prediction, all of these position-173 mutants bound to the IGLWKS peptide with a higher affinity than wild-type GID4. For example, the GID4T173A mutant bound to IGLWKS fourfold more tightly than did wild-type GID4 (Fig. 5C and SI Appendix, Table S3). The results were similar with the binding of position-173 GID4 mutants to the otherwise identical but Nt-Pro–bearing PGLWKS, except that the strongest binder was the GID4T173V mutant, in contrast to GID4T173A vis-à-vis IGLWKS (Fig. 5 C and D). On the assumption (to be verified) that the increased affinity exhibited by some GID4 derivatives altered at position-173 is not accompanied by a lowered specificity of binding, such mutants may prove particularly helpful in screens for physiological substrates of the Pro/N-degron pathway.

GID4-Dependent Degradation of a Protein Bearing the Nt-Ile Residue.

Previous work has shown that the S. cerevisiae and human GID4 N-recognins are not only sequelogous [similar in sequence (111)] and contain the above-described hydrophobic binding chamber (Figs. 4 and 5A), but are also similar in their recognition specificities vis-à-vis test proteins that bear, in particular, Nt-Pro (43, 44, 47, 48). We asked, therefore, whether S. cerevisiae GID4 may also, similarly to human GID4, recognize a non-Pro Nt-residue of a protein and in addition target that protein for the in vivo degradation by the Pro/N-degron pathway.

Protein degradation was assayed in yeast using the promoter reference technique (PRT) (74). In this method, both a protein of interest and a long-lived reference protein (dihydrofolate reductase, DHFR) are expressed in S. cerevisiae from the same plasmid and identical constitutive promoters that contain additional (PRT-specific) DNA elements. Once transcribed, these elements form specific 5′-RNA aptamers that can bind to the added (cell-penetrating) tetracycline (Tc). As a result, Tc, which does not inhibit global translation in the cytosol, can selectively repress translation of the aptamer-containing mRNAs that encode both the reference and test proteins (74). Advantages of PRT include the accuracy-increasing reference protein and the avoidance of cytotoxic, artifact-prone global translation inhibitors, such as cycloheximide in chase-degradation assays (74). Following the addition of Tc, a decrease in the amount of a test protein relative to the reference protein during a chase would signify degradation of the test protein.

We used PRT to ask whether yeast GID4 could target for degradation a test protein that comprises the C-terminally triple-flagged S. cerevisiae FBP13f gluconeogenic enzyme in which the Nt-Pro–bearing (and targetable by GID4) Nt-sequence PTLV (43) was replaced by Nt-IGLW. The latter has been identified as the Nt-sequence that could bind to human GID4 in vitro with a significant affinity (Kd of 16 μM) (Fig. 3 and SI Appendix, Fig. S1B). That affinity was, however, not as high as the affinity of the otherwise identical Nt-Pro–bearing Nt-sequence PGLW (Kd of 1.9 μM) (Fig. 3 and SI Appendix, Fig. S1A).

The initially present Nt-Met residue of a test protein is cotranslationally cleaved off by ribosome-associated MetAPs if a residue at position 2 (it would become N terminal after cleavage) is not larger than Val (2, 112). For example, the Pro residue at position 2 does not impede the MetAP-mediated removal of the initially present Nt-Met, a step that yields Nt-Pro (2, 112). In contrast, Nt-Ile, the Nt-residue of the human GID4-binding IGLW peptide, is larger than Val, and therefore would not become N terminal if Ile follows Nt-Met in a nascent polypeptide. The Ub fusion technique bypasses this problem by making it possible to expose, in vivo, any desired residue (except Pro) at the mature N terminus of a protein of interest (113). In this method, a protein is expressed as a linear Ub-X–protein fusion. The fusion’s Ub moiety is cotranslationally cleaved off by a family of deubiquitylating enzymes (present in all eukaryotes), yielding X-protein that bears the desired Nt-X residue (113).

S. cerevisiae cells carrying a PRT-based plasmid that expressed the 187-residue DHFR reference protein (tagged with both flag and ha epitopes) and a test protein—either Ub-MPTLV-FBP13f, Ub-MSTLV-FBP13f, Ub-IGLW-FBP13f, or Ub-MPGLW-FBP13f (43)—were grown in a glucose-containing minimal medium. In this setting, PTLV becomes the Nt-sequence of wild-type FBP1 after the cotranslational removal of its Nt-Met by MetAPs. Because of the removal of Nt-Met, both the MPTLV-FBP13f and MSTLV-FBP13f moieties of the above Ub fusions were present in vivo as the short-lived wild-type PTLV-FBP13f (derived from MPTLV-FBP13f) and the otherwise identical but long-lived STLV-FBP13f (derived from MSTLV-FBP13f) (43). The Nt-Ser residue is not recognized by GID4, in contrast to Nt-Pro (43, 44). The above Ub fusion-based versions of MPTLV-FBP13f and MSTLV-FBP13f served as controls, to verify the suitability of using the Ub fusion technique (113) to assay GID4 substrates for degradation by the Pro/N-degron pathway.

The in vivo translation of both a test protein and the DHFR reference was selectively repressed by the addition of Tc, thereby initiating a chase (74). As expected, PTLV-FBP13f (but not STLV-FBP13f) was short-lived in vivo. Degradation of PTLV-FBP13f required GID4, as no degradation was observed in gid4Δ cells (Fig. 6 C and D). Ub-MPGLW-FBP13f (becoming PGLW-FBP13f in vivo), whose Nt-Pro–bearing sequence PGLW could bind to GID4 in vitro (Figs. 2 and 3 and SI Appendix, Fig. S1A), was also short-lived in vivo, in a GID4-dependent manner (Fig. 6 A and B).

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

A protein bearing the GID4-binding, Prolacking N-terminal sequence Nt-IGLW can be targeted by the S. cerevisiae Pro/N-degron pathway for GID4-dependent degradation. The bands of test and reference (DHFR) proteins are indicated on the left. (A) Lane 1, kilodalton marker. Lanes 2 to 5, Tc/PRT-initiated chase assay (Results) with Ub-MPGLW-Fbp1f3 in wild-type S. cerevisiae. Lanes 6 to 9, same as in lanes 2 to 5, but with gid4Δ cells. Lanes 10 to 13, same as in lanes 2 to 5, but with Ub-IGLW-Fbp1f3. Lanes 14 to 17, same as in lanes 6 to 9 (gid4Δ cells) but with Ub-IGLW-Fbp1f3. (B) Quantification of data in A. Identities of specific curves are indicated below lane numbers. (C) Lanes 1 to 4, Tc/PRT-chase assay with Ub-MPTLV-Fbp1f3 in wild-type S. cerevisiae. Lanes 5 to 8, same as in lanes 1 to 4 but with gid4Δ cells. Lanes 9 to 12, same as lanes 1 to 4 but with Ub-MSTLV-Fbp1f3. Lanes 13 to 16, same as lanes 5 to 8 (gid4Δ cells), but with Ub-MSTLV-Fbp1f3. (D) Quantification of data in C. Identities of specific curves are indicated below lane numbers. All degradation assays were performed at least twice, yielding results that differed by less than 10%.

The IGLW-FBP13f protein (it became IGLW-FBP13f after the in vivo removal of Nt-Ub by DUBs), whose Nt-Ile–bearing Nt-sequence IGLW could bind to GID4 in vitro (Fig. 3 and SI Appendix, Fig. S1 B and G), was also short-lived in vivo (Fig. 6 A and B). The degradation of both PGLW-FBP13f and IGLW-FBP13f required GID4, as this degradation did not occur in gid4Δ cells (Fig. 6 A and B). Thus, the Pro-lacking Nt-sequence IGLW not only binds to GID4 but can also confer, on a test protein, a GID4-dependent degradation in S. cerevisiae (Figs. 3 and 6 A and B).

Interestingly, the GID4-dependent degradation of IGLW-FBP13f not only occurred but was even faster than the degradation of PGLW-FBP13f, although the in vitro affinity of human GID4 for the Nt-sequence IGLW (Kd of 16 μM) is significantly lower than the affinity of GID4 for the otherwise identical but Nt-Pro–bearing sequence PGLW (Kd of 1.9 μM) (Figs. 3 and 6 A and B and SI Appendix, Fig. S1 A, B, and G). Moreover, the early, prechase [“time-zero” (2, 35)] degradation of IGLW-FBP13f was also greater than the analogous degradation of PGLW-FBP13f (Fig. 6 A and B). Detailed reasons for the in vivo degradation of PGLW-FBP13f being slower than that of IGLW-FBP13f, despite the converse order of their in vitro affinities for GID4 remain to be understood. A plausible interpretation of these findings is as follows. Only one cotranslational in vivo cleavage (removal of the Nt-Ub moiety by DUBs) is required to produce the GID4-targetable IGLW-FBP13f protein from Ub-IGLW-FBP13f. In contrast, two obligatorily sequential cleavage steps, the removal of the Nt-Ub moiety and the removal of resulting Nt-Met by MetAPs, are required to produce the GID4-targetable PGLW-FBP13f protein from Ub-MPGLW-FBP13f. The resulting additional delay in generating PGLW-FBP13f (in contrast to no such delay in generating IGLW-FBP13f) may lead to a slower or incomplete removal of Nt-Met from MPGLW-FBP13f, the immediate precursor of PGLW-FBP13f.

In vivo levels of ribosome-associated MetAPs are significantly higher in the immediate vicinities of ribosomes than in the bulk solution. It is likely, therefore, that the two-step production of PGLW-FBP13f from the Ub-MPGLW-FBP13f is significantly less efficacious than the one-step (and MetAP-independent) production of IGLW-FBP13f from the Ub-IGLW-FBP13f. One likely reason for this inefficiency is that the N terminus of a nascent (being made) protein keeps moving away from a translating ribosome into bulk-solution regions that contain lower levels of MetAPs.

This model, to be addressed in future studies, predicts that the GID4-dependent degradation of PGLW-FBP13f that is produced, in one step, from MPGLW-FBP13f (Nt-Met can be cotranslationally removed if position 2 is occupied by Pro) would be faster than the degradation of the otherwise identical PGLW-FBP13f that is produced from Ub-MPGLW-FBP13f through the above two-step reaction. The degradation of PGLW-FBP13f that is produced through a single cleavage step is also predicted to be faster than the degradation of IGLW-FBP13f (which is produced from Ub-IGLW-FBP13f by DUBs), because of the difference in binding affinities of GID4 for Nt-PGLW vs. Nt-IGLW (Fig. 3 and SI Appendix, Fig. S1 A, B, and G).

Concluding Remarks.

We have shown that in the presence of cognate downstream motifs, human GID4, the main recognin of the Pro/N-degron pathway, can recognize not only the Nt-Pro residue but a few other hydrophobic Nt-residues as well (Figs. 1–3 and SI Appendix, Fig. S1). We solved crystal structures of human GID4 bound to peptides that bear either Nt-Ile or Nt-Val (Figs. 4 and 5A). We also used site-directed mutagenesis of GID4 to analyze the roles of GID4 residues in the binding of substrates by this N-recognin (Fig. 5 and SI Appendix, Tables S2 and S3). These approaches determined contributions of specific GID4 residues to the GID4-mediated recognition of the Nt-Pro residue versus hydrophobic residues other than Pro. We also found that the S. cerevisiae GID4 N-recognin can target a protein bearing an Nt-sequence, such as Nt-IGLW (which lacks both Nt-Pro and a Pro at position 2) for rapid degradation by the Pro/N-degron pathway in vivo (Fig. 6).

The Nt-Ile residue of the sequence such as Nt-IGLW can be recognized as a destabilizing one not only by GID4 of the Pro/N-degron pathway but also, for example, by S. cerevisiae UBR1, the N-recognin of the yeast Arg/N-degron pathway, except that Nt-Ile binds to UBR1 less strongly than other UBR1-recognized destabilizing Nt-residues (2). With that caveat, it is possible that some proteins (or protein fragments, since Nt-Ile would not be normally exposed at a nascent protein’s N terminus; see above) might be targetable, independently, by both the Pro/N-degron and Arg/N-degron pathways.

The known physiological substrates of the S. cerevisiae Pro/N-degron pathway are the gluconeogenic enzymes FBP1, ICL1, MDH2, and PCK1. All four of these proteins are conditionally polyubiquitylated and destroyed by the S. cerevisiae GID Ub ligase and the proteasome (Introduction). The GID ligase targets FBP1, ICL1, MDH2, and PCK1 via GID4, the main N-recognin of GID that binds to Nt-Pro residues (in FBP1, ICL1, and MDH2) or to a Pro at position 2 (in PCK1), in the also required presence of adjoining motifs (2, 43⇓–45, 48, 96).

The S. cerevisiae genome encodes about 300 proteins that are expected to bear Nt-Pro (43). However, at least a majority of these proteins do not appear to be substrates of GID4 N-recognin, in contrast to FBP1, ICL1, and MDH2 (43, 47, 48). In addition, it remains to be determined whether there are physiological substrates of S. cerevisiae GID4 other than PCK1 that are targeted, at least in part, through their Pro at position 2, analogously to PCK1.

In vertebrates, including mammals, the GID (CTLH) Ub ligase functions in primary cilia, in cell proliferation, and in other processes, including apparently, glucose sensing and energy homeostasis (refs. 96 and 102⇓⇓⇓⇓⇓⇓⇓–110 and references therein). While the Pro residue at position 2 is strongly conserved among both fungal and vertebrate PCK1 enzymes, the Nt-Pro residues of S. cerevisiae FBP1, ICL1, and MDH2 are weakly conserved even among fungi, and are absent, for example, from mammalian counterparts of these enzymes. In addition, the mammalian versions of S. cerevisiae FBP1, ICL1, and MDH2 are apparently not targeted for degradation by the GID (CTLH) Ub ligase (refs. 96 and 102⇓⇓⇓⇓⇓⇓⇓–110 and references. therein).

In sum, little is known about physiological substrates of S. cerevisiae GID4 outside the set of yeast gluconeogenic enzymes (Fig. 1) (43, 47, 48). As to human GID4, its Nt-Pro–bearing physiological substrates remain to be identified (44). It is also unknown whether some non-GID4 main subunits of the GID Ub ligase (Introduction) might also function as its targeting components (of currently unknown specificity), in addition to and independently of GID4.

One ramification of results in the present study is that they will facilitate discovery of physiological substrates of the Pro/N-degron pathway, since potential GID4 substrates are no longer confined to proteins that bear Nt-Pro or a Pro at position 2. In addition, our findings deepened the previously revealed similarity of target recognition by the S. cerevisiae and human GID4 N-recognins by expanding their substrate range from interactions with Nt-Pro or a Pro at position 2 to their demonstrated interactions, in a functionally relevant manner, with specific Nt-residues other than Pro (Figs. 1–6).

Materials and Methods

Antibodies and Other Reagents.

The following primary antibodies were used for immunoblotting: Antihemagglutinin (ha) tag monoclonal antibody (Sigma, H6908) and anti-flag M2 monoclonal antibody (Sigma, F1804). Secondary antibodies for immunoblotting were Li-Cor IRDye-conjugated goat anti-rabbit 680RD (Li-Cor, C51104-08) or anti-mouse 800CW (Li-Cor, #C60405-05). Fluorescence was detected and quantified using Odyssey 9120 (Li-Cor). The UltraCruz protease inhibitor mixture tablet (EDTA-free) was from Santa Cruz Biotechnology. A variety of restriction enzymes (used for plasmid construction), T4 DNA ligase, and Q5 DNA polymerase were from New England Biolabs. Tc and glucose were from Sigma. Short synthetic peptides used in this study were produced by Apeptide Co.

Yeast Strains and Media.

The S. cerevisiae strains used in this study were BY4741 (MATa his3Δ1 leu2Δ met15Δ ura3Δ) and BY3244 (gid4Δ derivative of BY4741). Standard techniques were used for constructing plasmids and yeast strains (114, 115). Yeast media included YPD medium (1% yeast extract, 2% peptone, 2% glucose); SC medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% glucose, supplemented with compounds required by auxotrophic yeast strains); SE medium (the same as SC but with 2% ethanol instead of glucose). Yeast nitrogen base with ammonium sulfate as well as supplement mixtures of amino acids for S. cerevisiae growth were from MP Biomedicals. Yeast extract and yeast peptone were from Difco.

Cloning, Expression, and Purification of Human GID4.

DNA sequence encoding the full-length human GID4 was amplified by PCR from the human mammalian gene collection of cDNA clones (Open Biosystems), and was cloned into pET28GST-LIC vector encoding a GST tag at the N terminus. After transformation of the resulting plasmid into Escherichia coli BL21 (DE3), cells were grown in Terrific Broth (TB) medium (Sigma-Aldrich) at 37 °C until OD600 of 1.0 and induced with a final concentration of 0.3 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) for protein expression at 16 °C overnight. Cells were harvested by centrifugation, the pellet was resuspended in lysis buffer (0. 5M NaCl, 5% glycerol, 2 mM β-mercaptoethanol, 20 mM Tris⋅HCl pH 7.5), and cells were disrupted by sonication. The resulting sample was centrifuged at 12,000 × g for 1 h at 4 °C. The supernatant was loaded onto a glutathione-Sepharose column and washed with lysis buffer. The GID4 protein was eluted with 10 mM glutathione and further purified by gel filtration on Superdex 200 column (GE Healthcare). GID4124−289 and other relevant mutants were expressed and purified as described previously (44).

Protein Crystallization.

Crystallization experiments were performed at 18 °C using sitting-drop vapor-diffusion method, by mixing 1 μL of protein solution and 1 μL of reservoir solution. Prior to setting up crystallization trials, purified human GID4124−289 was incubated with the IGLWKS or the VGLWKS peptide for 1 h on ice at a molar ratio of 1:1.5. Crystals of the GID4-IGLWKS complex were obtained in the crystallization buffer (20% [wt/vol] polyethylene glycol [PEG]-3350 and 8% [vol/vol] Tacsimate, [Hampton Research], pH 7.0). Crystals of the GID4-VGLWKS complex were obtained in 20% (wt/vol) PEG-3350, 0.03 M citrate, pH 7.6. The crystals were cryoprotected by adding 20% (vol/vol) glycerol to the reservoir, followed by flash-cooling in liquid N2 and storage in liquid N2 until data collection.

Data Collection and Structure Determination.

Diffraction images of GID4 crystals containing the complexes GID4-IGLWKS or GID4-VGLWKS where collected at Advanced Photon Source beam line 24-ID-E and Canadian Light Source beam line 08ID, respectively, and processed using XDS (116) and AIMLESS programs (117). The structures were solved by molecular replacement with the program PHASER (118) and coordinates from an early model of PDB ID code 6CCR (44). The models were refined with REFMAC (119) and rebuilt with COOT (120).

Isothermal Titration Calorimetry.

ITC measurements were carried out at 25 °C using VP-ITC instrument (Microcal). Purified proteins and peptides were prepared in the titration buffer containing 0.1 M NaCl, 0.5 mM TECP [Tris (2-carboxyethyl) phosphine], 20 mM Tris⋅HCl, pH 7.5. For a typical experiment, 1 to 2 mM of peptide solution was titrated into 50 to 100 μM of protein solution with 26 injections of 10 μL each spaced by 180 s, and with a reference power of 15 μ cal/s. ITC data were analyzed using a one-site binding model and Origin 7.0 program (OriginLab).

Tc/PRT Chase-Degradation Assays.

For quantifying the in vivo degradation of specific proteins in S. cerevisiae, we used the Tc-based PRT (Tc/PRT) (Results) (43, 47, 63, 74). Plasmids for these assays used pJO629 as the parental plasmid and were constructed as described previously (74). The pCSJ982 plasmid expressed, in S. cerevisiae from the PTDH3-based promoter, the C-terminally triple-flagged Ub fusion Ub-MPGLW-Fbp13f, in which the wild-type MPTLV N-terminal sequence of Fbp1 was replaced by MPGLW. Briefly, to construct pCSJ982, a Ub-MPGLW-Fbp13f–encoding DNA fragment was amplified by a two-step PCR from S. cerevisiae genomic DNA and pBW227 (a Ub-encoding plasmid), using, initially, the primers CSJ800 (5′-ATA​TAT​GGC​GCG​CCA​TGC​AGA​TCT​TTG​TGA​AGA​C-3′) and CSJ1021 (5′-CA AAC​CCT​TCG​GTA​GAG​TCT​CTT​CTT​GGT​CCA​TTC​CAC​AAA​CCT​GG-CAT​ACC​ACC​GCG​GAG​GCG​CAA​CAC-3′), and thereafter the primers CSJ800 and CSJ182 (5′-ATATATGCGGCC GCT​TAC​TTG​TCA​TCG​TCA​TCC​TTG​TAA​TCG​ATA​TCA​T-GAT​CTT​TAT​AAT​CAC​CGT​C-3′). The resulting PCR-produced DNA fragment was digested with AscI/NotI and ligated into AscI/NotI-cut pJO629 downstream of its PTDH3-based promoter, yielding pCSJ982. To alter the N-terminal sequence of Fbp1 in the Ub fusion proteins of the above design, the same protocol was used, but different primer sets for the first-round PCR. Specific first-round PCR reactions used different primer sets, the primers CSJ800 and CSJ1023 (5′-CAAACCCTTC GGT​AGA​GTC​TCT​TCT​TGG​TCC​ATT​CCA​CAA​ACC​AAT-ACC​ACC​GCG​GAG​GCG​CAA​CAC-3′), the primers CSJ800 and CSJ1024 (5′-GAG​TCT​CTT​CTT​GGT​CCA​TTT​ACT​AGA​GTT​GG-CAT​ACC​ACC​GCG​GAG​GCG​CAA​CAC-3′), or the primers CSJ800 and CSJ1025 (5′-GAG​TCT​CTT​CTT​GGT​CCA​TTT​ACT​AGA​GTA​GAC​ATA​CCA​CCG​CGG​AGG​CGC​A-ACA​C-3′), followed by the same steps as above (second-step PCR and subsequent procedures, including DNA ligation) to construct pCSJ984, which expressed Ub-IGLW-Fbp13f, pCSJ985 (which expressed Ub-MPTLV-Fbp13f), and pCSJ986 (which expressed Ub-MSTLV-Fbp13f). Additional details are available upon request. All final constructs were verified by DNA sequencing.

Tc/PRT chase-degradation assays (74) were carried out as described in Results. Briefly, batch yeast cultures were grown in SC medium overnight. Cells were centrifuged at 11,200 × g for 1 min, washed once in prewarmed PBS buffer, then resuspended in SE (ethanol as the carbon source) to OD600 of 0.5 and allowed cells to grow in the respective media for 20 h at 30 °C. Cells were collected by centrifugation, resuspended in fresh SC to the final OD600 of 1.0, with Tc at 0.5 mM, and the tube was incubated at 30 °C, with gentle rocking. At indicated time intervals (including the beginning of incubation), equal-volume samples were collected, and cells were pelleted by centrifugation. Cell pellets were resuspended in 1 mL of 1 M NaOH, and incubated at room temperature for 5 min. Cell were again collected by centrifugation (at the top speed in a microcentrifuge for 1 min), and resuspended in 50 μL of buffer HU (8 M urea, 5% SDS, 1 mM EDTA, 0.1 M DTT, 0.005% bromophenol blue, 0.2 M Tris⋅HCl, pH 6.8). These protein solutions were incubated at 70 °C for 10 min. Samples were fractionated by SDS/PAGE on 4 to 12% NuPAGE Bis⋅Tris gels with Mops running buffer (ThermoFisher), followed by immunoblotting, as described previously (57, 58, 63, 74), using anti-flag (1:2,000), anti-myc (1:1,000), and anti-ha (1:2,000) antibodies, as well as a secondary antibody (or antibodies). Immunoblot patterns were imaged and quantified using the Odyssey 9120 instrument (Li-Cor Biotechnologies), its software, and manufacturer’s manual. All Tc/PRT chases in this study were repeated at least twice (often thrice), with results differing by 10% or less.

GID4 Binding Assays with Peptide Arrays.

Peptide arrays were synthesized on cellulose membrane using the SPOT synthesis method (121) and Autospot Multipep system (Intavis). Each spot contained ∼9 nmols of peptide (Autospot Reference Handbook, Intavis) and the successful synthesis of peptides on the cellulose membrane was qualitatively confirmed by bromophenol blue staining. A peptide array was blocked overnight at 5% milk-PBST solution at 4 °C, 1× PBST is 0.05% Tween 20, 0.14 M NaCl, 2.7 mM KCL, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.5). Thereafter the membrane was washed three times for 5 min with, and the peptide array was preincubated for 5 min in interaction buffer (10% glycerol, 0.1 M KCl, 1 mM EDTA, 20 mM Hepes pH 7.5). The array was then incubated for 1 h at room temperature in the interaction buffer containing 50 nM GST-tagged GID4. The membrane was washed three times for 5 min in 1× PBST, followed by incubation 1 h at room temperature with the primary antibody to GST (1:6,000, anti-GST, polyclonal; GE Healthcare, cat. no. 10595345). After repetition of the washing, the membrane was incubated for 1 h at room temperature with secondary antibody (1:12,000, anti-goat IgG [whole-molecule]-peroxidase antibody produced in rabbit; Sigma-Aldrich, cat. No. A4174). The signal was detected by chemilumenescence using a Hyperfilm TM high-performance autoradiography film (GE Healthcare). GID4 binding assays were carried out twice. The data were normalized and the average binding of GID4 to each peptide was calculated. SDs of the spot intensities were calculated for each spot as well, and a sequence logo was prepared using WebLogo (weblogo.berkeley.edu/).

Data Availability.

The atomic coordinates and structure factors of GID4-IGLWKS and GID4-VGLWKS complexes have been deposited in the Protein Data Bank (https://www.rcsb.org/) under the accession codes 6WZX and 6WZZ, respectively. All other relevant data in the paper are entirely available through both text and figures in the main text and SI Appendix (122, 123).

Acknowledgments

We thank Wolfram Tempel for help with data collection and structure determination. Experimental data of this study were produced, in part, through experiments at the Argonne National Laboratory and Structural Biology Center at the Advanced Photon Source. The Structural Biology Center Collaborative Access Team is operated by the University of Chicago Argonne, LLC, for the US Department of Energy and the Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work is supported by Natural Sciences and Engineering Research Council Grant RGPIN-2016-06300 and by the Structural Genomics Consortium (to J.M.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through the Ontario Genomics Institute (OGI-055), Innovative Medicines Initiative (European Union/European Federation of Pharmaceutical Industries and Associations) (ULTRA-DD Grant 115766), Janssen, Merck, Novartis Pharma AG, Ontario Ministry of Research, Innovation, and Science, Pfizer, São Paulo Research Foundation-Fundaçao de Amparo à Pesquisa do Estado de Sao Paulo, Takeda, and Wellcome. This work was also supported by the National Natural Science Foundation of China, Grant 31900865 (to C.D.) and by the NIH Grants 1R01DK039520 and 1R01GM031530 (to A.V.).

Footnotes

  • ↵1C.D. and S.-J.C. contributed equally to this work.

  • ↵2To whom correspondence may be addressed. Email: avarsh{at}caltech.edu or jr.min{at}utoronto.ca.
  • Author contributions: C.D., S.-J.C., A.M., A.J., A.V., and J.M. designed research; C.D., S.-J.C., A.M., S.W., and K.S. performed research; C.D., S.-J.C., A.M., S.W., K.S., A.J., A.V., and J.M. analyzed data; and C.D., S.-J.C., A.M., A.J., A.V., and J.M. wrote the paper.

  • The authors declare no competing interest.

  • This article is a PNAS Direct Submission.

  • Data deposition: The atomic coordinates and structure factors of GID4-IGLWKS and GID4-VGLWKS complexes have been deposited in the Protein Data Bank (https://www.rcsb.org/) under the accession codes 6WZX and 6WZZ, respectively.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2007085117/-/DCSupplemental.

Published under the PNAS license.

View Abstract

References

  1. 1.↵
    1. A. Hershko,
    2. A. Ciechanover,
    3. A. Varshavsky
    , The ubiquitin system. Nat. Med. 6, 1073–1081 (2000).
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. A. Varshavsky
    , N-degron and C-degron pathways of protein degradation. Proc. Natl. Acad. Sci. U.S.A. 116, 358–366 (2019).
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. A. Varshavsky
    , Discovery of cellular regulation by protein degradation. J. Biol. Chem. 283, 34469–34489 (2008).
    OpenUrlFREE Full Text
  4. 4.↵
    1. D. Finley,
    2. H. D. Ulrich,
    3. T. Sommer,
    4. P. Kaiser
    , The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics 192, 319–360 (2012).
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. G. Kleiger,
    2. T. Mayor
    , Perilous journey: A tour of the ubiquitin-proteasome system. Trends Cell Biol. 24, 352–359 (2014).
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Y. Ohsumi
    , Historical landmarks of autophagy research. Cell Res. 24, 9–23 (2014).
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. V. Lahiri,
    2. W. D. Hawkins,
    3. D. J. Klionsky
    , Watch what you (self-) eat: Autophagic mechanisms that modulate metabolism. Cell Metab. 29, 803–826 (2019).
    OpenUrlCrossRef
  8. 8.↵
    1. E. M. Sontag,
    2. R. S. Samant,
    3. J. Frydman
    , Mechanisms and functions of spatial protein quality control. Annu. Rev. Biochem. 86, 97–122 (2017).
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. V. Vittal,
    2. M. D. Stewart,
    3. P. S. Brzovic,
    4. R. E. Klevit
    , Regulating the regulators: Recent revelations in the control of E3 ubiquitin ligases. J. Biol. Chem. 290, 21244–21251 (2015).
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. M. Rape
    , Ubiquitylation at the crossroads of development and disease. Nat. Rev. Mol. Cell Biol. 19, 59–70 (2018).
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. C. Enam,
    2. Y. Geffen,
    3. T. Ravid,
    4. R. G. Gardner
    , Protein quality control degradation in the nucleus. Annu. Rev. Biochem. 87, 725–749 (2018).
    OpenUrl
  12. 12.↵
    1. N. Zheng,
    2. N. Shabek
    , Ubiquitin ligases: Structure, function, and regulation. Annu. Rev. Biochem. 86, 129–157 (2017).
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. A. Shiber et al.
    , Cotranslational assembly of protein complexes in eukaryotes revealed by ribosome profiling. Nature 561, 268–272 (2018).
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. P. Grumati,
    2. I. Dikic
    , Ubiquitin signaling and autophagy. J. Biol. Chem. 293, 5404–5413 (2018).
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. C. H. Ji,
    2. Y. T. Kwon
    , Crosstalk and interplay between the ubiquitin-proteasome system and autophagy. Mol. Cells 40, 441–449 (2017).
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. S. Shao,
    2. R. S. Hegde
    , Target selection during protein quality control. Trends Biochem. Sci. 41, 124–137 (2016).
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. F. Wang,
    2. L. A. Canadeo,
    3. J. M. Huibregtse
    , Ubiquitination of newly synthesized proteins at the ribosome. Biochimie 114, 127–133 (2015).
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. D. Balchin,
    2. M. Hayer-Hartl,
    3. F. U. Hartl
    , In vivo aspects of protein folding and quality control. Science 353, aac4354 (2016).
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. D. Zattas,
    2. M. Hochstrasser
    , Ubiquitin-dependent protein degradation at the yeast endoplasmic reticulum and nuclear envelope. Crit. Rev. Biochem. Mol. Biol. 50, 1–17 (2015).
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. K. K. Dove,
    2. R. E. Klevit
    , RING-between-RING E3 ligases: Emerging themes amid the variations. J. Mol. Biol. 429, 3363–3375 (2017).
    OpenUrlCrossRef
  21. 21.↵
    1. C. A. P. Joazeiro
    , Ribosomal stalling during translation: Providing substrates for ribosome-associated protein quality control. Annu. Rev. Cell Dev. Biol. 33, 343–368 (2017).
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. T. Inobe,
    2. S. Fishbain,
    3. S. Prakash,
    4. A. Matouschek
    , Defining the geometry of the two-component proteasome degron. Nat. Chem. Biol. 7, 161–167 (2011).
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. N. P. Dantuma,
    2. L. C. Bott
    , The ubiquitin-proteasome system in neurodegenerative diseases: Precipitating factor, yet part of the solution. Front. Mol. Neurosci. 7, 70 (2014).
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. B. A. Schulman
    , Twists and turns in ubiquitin-like protein conjugation cascades. Protein Sci. 20, 1941–1954 (2011).
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. J. A. M. Bard et al.
    , Structure and function of the 26S proteasome. Annu. Rev. Biochem. 87, 697–724 (2018).
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. A. Schweitzer et al.
    , Structure of the human 26S proteasome at a resolution of 3.9 Å. Proc. Natl. Acad. Sci. U.S.A. 113, 7816–7821 (2016).
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. D. Finley,
    2. X. Chen,
    3. K. J. Walters
    , Gates, channels, and switches: Elements of the proteasome machine. Trends Biochem. Sci. 41, 77–93 (2016).
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. G. A. Collins,
    2. A. L. Goldberg
    , The logic of the 26S proteasome. Cell 169, 792–806 (2017).
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. L. Budenholzer,
    2. C. L. Cheng,
    3. Y. Li,
    4. M. Hochstrasser
    , Proteasome structure and assembly. J. Mol. Biol. 429, 3500–3524 (2017).
    OpenUrl
  30. 30.↵
    1. D. Gödderz et al.
    , Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation. Sci. Rep. 5, 7615 (2015).
    OpenUrlCrossRef
  31. 31.↵
    1. H. Yu,
    2. A. Matouschek
    , Recognition of client proteins by the proteasome. Annu. Rev. Biophys. 46, 149–173 (2017).
    OpenUrl
  32. 32.↵
    1. B. M. Stadtmueller,
    2. C. P. Hill
    , Proteasome activators. Mol. Cell 41, 8–19 (2011).
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. A. Bachmair,
    2. D. Finley,
    3. A. Varshavsky
    , In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179–186 (1986).
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. A. Bachmair,
    2. A. Varshavsky
    , The degradation signal in a short-lived protein. Cell 56, 1019–1032 (1989).
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. A. Varshavsky
    , The N-end rule pathway and regulation by proteolysis. Protein Sci. 20, 1298–1345 (2011).
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. J. W. Tobias,
    2. T. E. Shrader,
    3. G. Rocap,
    4. A. Varshavsky
    , The N-end rule in bacteria. Science 254, 1374–1377 (1991).
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. H. Rao,
    2. F. Uhlmann,
    3. K. Nasmyth,
    4. A. Varshavsky
    , Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability. Nature 410, 955–959 (2001).
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. D. A. Dougan,
    2. D. Micevski,
    3. K. N. Truscott
    , The N-end rule pathway: From recognition by N-recognins, to destruction by AAA+proteases. Biochim. Biophys. Acta 1823, 83–91 (2012).
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. T. Tasaki,
    2. S. M. Sriram,
    3. K. S. Park,
    4. Y. T. Kwon
    , The N-end rule pathway. Annu. Rev. Biochem. 81, 261–289 (2012).
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. D. J. Gibbs,
    2. J. Bacardit,
    3. A. Bachmair,
    4. M. J. Holdsworth
    , The eukaryotic N-end rule pathway: Conserved mechanisms and diverse functions. Trends Cell Biol. 24, 603–611 (2014).
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. N. Dissmeyer,
    2. S. Rivas,
    3. E. Graciet
    , Life and death of proteins after protease cleavage: Protein degradation by the N-end rule pathway. New Phytol. 218, 929–935 (2018).
    OpenUrl
  42. 42.↵
    1. M. A. Eldeeb,
    2. L. C. A. Leitao,
    3. R. P. Fahlman
    , Emerging branches of the N-end rule pathways are revealing the sequence complexities of N-termini dependent protein degradation. Biochem. Cell Biol. 96, 289–294 (2018).
    OpenUrl
  43. 43.↵
    1. S. J. Chen,
    2. X. Wu,
    3. B. Wadas,
    4. J.-H. Oh,
    5. A. Varshavsky
    , An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes. Science 355, 366 (2017).
    OpenUrl
  44. 44.↵
    1. C. Dong et al.
    , Molecular basis of GID4-mediated recognition of degrons for the Pro/N-end rule pathway. Nat. Chem. Biol. 14, 466–473 (2018).
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. D. A. Dougan,
    2. A. Varshavsky
    , Understanding the Pro/N-end rule pathway. Nat. Chem. Biol. 14, 415–416 (2018).
    OpenUrl
  46. 46.↵
    1. S. Qiao et al.
    , Interconversion between anticipatory and active GID E3 ubiquitin ligase conformations via metabolically driven substrate receptor assembly. Mol. Cell 77, 150–163.e9 (2020).
    OpenUrl
  47. 47.↵
    1. A. Melnykov,
    2. S. J. Chen,
    3. A. Varshavsky
    , Gid10 as an alternative N-recognin of the Pro/N-degron pathway. Proc. Natl. Acad. Sci. U.S.A. 116, 15914–15923 (2019).
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. S. J. Chen,
    2. A. Melnykov,
    3. A. Varshavsky
    , Evolution of substrates and components of the Pro/N-degron pathway. Biochemistry 59, 582–593 (2020).
    OpenUrl
  49. 49.↵
    1. K. I. Piatkov,
    2. T. T. Vu,
    3. C. S. Hwang,
    4. A. Varshavsky
    , Formyl-methionine as a degradation signal at the N-termini of bacterial proteins. Microb. Cell 2, 376–393 (2015).
    OpenUrl
  50. 50.↵
    1. J. M. Kim et al.
    , Formyl-methionine as an N-degron of a eukaryotic N-end rule pathway. Science 362, eaat0174 (2018).
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. M. K. Kim,
    2. S. J. Oh,
    3. B. G. Lee,
    4. H. K. Song
    , Structural basis for dual specificity of yeast N-terminal amidase in the N-end rule pathway. Proc. Natl. Acad. Sci. U.S.A. 113, 12438–12443 (2016).
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. T. Szoradi et al.
    , SHRED is a regulatory cascade that reprograms Ubr1 substrate specificity for enhanced protein quality control during stress. Mol. Cell 70, 1025–1037.e5 (2018).
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. C. S. Hwang,
    2. A. Shemorry,
    3. A. Varshavsky
    , N-terminal acetylation of cellular proteins creates specific degradation signals. Science 327, 973–977 (2010).
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. H. K. Kim et al.
    , The N-terminal methionine of cellular proteins as a degradation signal. Cell 156, 158–169 (2014).
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. R.-G. Hu et al.
    , The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 437, 981–986 (2005).
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. S. T. Kim et al.
    , The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins. PLoS One 13, e0202260 (2018).
    OpenUrl
  57. 57.↵
    1. K. T. Nguyen et al.
    , N-terminal acetylation and the N-end rule pathway control degradation of the lipid droplet protein PLIN2. J. Biol. Chem. 294, 379–388 (2019).
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. A. Shemorry,
    2. C. S. Hwang,
    3. A. Varshavsky
    , Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway. Mol. Cell 50, 540–551 (2013).
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. B. Wadas et al.
    , Degradation of serotonin N-acetyltransferase, a circadian regulator, by the N-end rule pathway. J. Biol. Chem. 291, 17178–17196 (2016).
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. B. Wadas,
    2. K. I. Piatkov,
    3. C. S. Brower,
    4. A. Varshavsky
    , Analyzing N-terminal arginylation through the use of peptide arrays and degradation assays. J. Biol. Chem. 291, 20976–20992 (2016).
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    1. M. M. Rinschen et al.
    , The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. Hum. Mol. Genet. 25, 1328–1344 (2016).
    OpenUrlCrossRefPubMed
  62. 62.↵
    1. R. F. Shearer,
    2. M. Iconomou,
    3. C. K. Watts,
    4. D. N. Saunders
    , Functional roles of the E3 ubiquitin ligase UBR5 in cancer. Mol. Cancer Res. 13, 1523–1532 (2015).
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. J. H. Oh,
    2. J. Y. Hyun,
    3. A. Varshavsky
    , Control of Hsp90 chaperone and its clients by N-terminal acetylation and the N-end rule pathway. Proc. Natl. Acad. Sci. U.S.A. 114, E4370–E4379 (2017).
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. E. Graciet et al.
    , Aminoacyl-transferases and the N-end rule pathway in a human pathogen. Proc. Natl. Acad. Sci. U.S.A. 103, 3078–3083 (2006).
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. R. Schmidt,
    2. R. Zahn,
    3. B. Bukau,
    4. A. Mogk
    , ClpS is the recognition component for Escherichia coli substrates of the N-end rule degradation pathway. Mol. Microbiol. 72, 506–517 (2009).
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. I. Rivera-Rivera,
    2. G. Román-Hernández,
    3. R. T. Sauer,
    4. T. A. Baker
    , Remodeling of a delivery complex allows ClpS-mediated degradation of N-degron substrates. Proc. Natl. Acad. Sci. U.S.A. 111, E3853–E3859 (2014).
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    1. S. M. Shim et al.
    , The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation. Sci. Signal. 11, eaan0630 (2018).
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    1. Y. D. Yoo et al.
    , N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis. Proc. Natl. Acad. Sci. U.S.A. 115, E2716–E2724 (2018).
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. S. Sekine,
    2. R. J. Youle
    , PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol. BMC Biol. 16, 2 (2018).
    OpenUrlCrossRefPubMed
  70. 70.↵
    1. B. P. Weaver,
    2. Y. M. Weaver,
    3. S. Mitani,
    4. M. Han
    , Coupled caspase and N-end rule ligase activities allow recognition and degradation of pluripotency factor LIN-28 during non-apoptotic development. Dev. Cell 41, 665–673.e6 (2017).
    OpenUrlCrossRef
  71. 71.↵
    1. K. Kitamura,
    2. H. Fujiwara
    , The type-2 N-end rule peptide recognition activity of Ubr11 ubiquitin ligase is required for the expression of peptide transporters. FEBS Lett. 587, 214–219 (2013).
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. J. Vicente et al.
    , The Cys-Arg/N-end rule pathway is a general sensor of abiotic stress in flowering plants. Curr. Biol. 27, 3183–3190.e4 (2017).
    OpenUrlCrossRefPubMed
  73. 73.↵
    1. H. Aksnes,
    2. A. Drazic,
    3. M. Marie,
    4. T. Arnesen
    , First things first: Vital protein marks by N-terminal acetyltransferases. Trends Biochem. Sci. 41, 746–760 (2016).
    OpenUrlCrossRefPubMed
  74. 74.↵
    1. J. H. Oh,
    2. S. J. Chen,
    3. A. Varshavsky
    , A reference-based protein degradation assay without global translation inhibitors. J. Biol. Chem. 292, 21457–21465 (2017).
    OpenUrlAbstract/FREE Full Text
  75. 75.↵
    1. K. I. Piatkov,
    2. C. S. Brower,
    3. A. Varshavsky
    , The N-end rule pathway counteracts cell death by destroying proapoptotic protein fragments. Proc. Natl. Acad. Sci. U.S.A. 109, E1839–E1847 (2012).
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    1. K. I. Piatkov,
    2. L. Colnaghi,
    3. M. Békés,
    4. A. Varshavsky,
    5. T. T. Huang
    , The auto-generated fragment of the Usp1 deubiquitylase is a physiological substrate of the N-end rule pathway. Mol. Cell 48, 926–933 (2012).
    OpenUrlCrossRefPubMed
  77. 77.↵
    1. K. I. Piatkov,
    2. J.-H. Oh,
    3. Y. Liu,
    4. A. Varshavsky
    , Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway. Proc. Natl. Acad. Sci. U.S.A. 111, E817–E826 (2014).
    OpenUrlAbstract/FREE Full Text
  78. 78.↵
    1. C. S. Brower,
    2. K. I. Piatkov,
    3. A. Varshavsky
    , Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway. Mol. Cell 50, 161–171 (2013).
    OpenUrlCrossRefPubMed
  79. 79.↵
    1. D. Justa-Schuch et al.
    , DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. eLife 5, e16370 (2016).
    OpenUrlCrossRefPubMed
  80. 80.↵
    1. K. T. Nguyen,
    2. J. M. Kim,
    3. S. E. Park,
    4. C. S. Hwang
    , N-terminal methionine excision of proteins creates tertiary destabilizing N-degrons of the Arg/N-end rule pathway. J. Biol. Chem. 294, 4464–4476 (2019).
    OpenUrlAbstract/FREE Full Text
  81. 81.↵
    1. J. E. Flack,
    2. J. Mieszczanek,
    3. N. Novcic,
    4. M. Bienz
    , Wnt-dependent inactivation of the Groucho/TLE co-repressor by the HECT E3 ubiquitin ligase Hyd/UBR5. Mol. Cell 67, 181–193.e5 (2017).
    OpenUrlCrossRef
  82. 82.↵
    1. B. Braun et al.
    , Gid9, a second RING finger protein contributes to the ubiquitin ligase activity of the Gid complex required for catabolite degradation. FEBS Lett. 585, 3856–3861 (2011).
    OpenUrlCrossRefPubMed
  83. 83.↵
    1. C. R. Brown,
    2. A. B. Wolfe,
    3. D. Cui,
    4. H. L. Chiang
    , The vacuolar import and degradation pathway merges with the endocytic pathway to deliver fructose-1,6-bisphosphatase to the vacuole for degradation. J. Biol. Chem. 283, 26116–26127 (2008).
    OpenUrlAbstract/FREE Full Text
  84. 84.↵
    1. G.-C. Hung,
    2. C. R. Brown,
    3. A. B. Wolfe,
    4. J. Liu,
    5. H.-L. Chiang
    , Degradation of the gluconeogenic enzymes fructose-1,6-bisphosphatase and malate dehydrogenase is mediated by distinct proteolytic pathways and signaling events. J. Biol. Chem. 279, 49138–49150 (2004).
    OpenUrlAbstract/FREE Full Text
  85. 85.↵
    1. J. Juretschke,
    2. R. Menssen,
    3. A. Sickmann,
    4. D. H. Wolf
    , The Hsp70 chaperone Ssa1 is essential for catabolite induced degradation of the gluconeogenic enzyme fructose-1,6-bisphosphatase. Biochem. Biophys. Res. Commun. 397, 447–452 (2010).
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. R. Menssen et al.
    , Exploring the topology of the Gid complex, the E3 ubiquitin ligase involved in catabolite-induced degradation of gluconeogenic enzymes. J. Biol. Chem. 287, 25602–25614 (2012).
    OpenUrlAbstract/FREE Full Text
  87. 87.↵
    1. J. Regelmann et al.
    , Catabolite degradation of fructose-1,6-bisphosphatase in the yeast Saccharomyces cerevisiae: A genome-wide screen identifies eight novel GID genes and indicates the existence of two degradation pathways. Mol. Biol. Cell 14, 1652–1663 (2003).
    OpenUrlAbstract/FREE Full Text
  88. 88.↵
    1. O. Santt et al.
    , The yeast GID complex, a novel ubiquitin ligase (E3) involved in the regulation of carbohydrate metabolism. Mol. Biol. Cell 19, 3323–3333 (2008).
    OpenUrlAbstract/FREE Full Text
  89. 89.↵
    1. T. Schüle,
    2. M. Rose,
    3. K. D. Entian,
    4. M. Thumm,
    5. D. H. Wolf
    , Ubc8p functions in catabolite degradation of fructose-1, 6-bisphosphatase in yeast. EMBO J. 19, 2161–2167 (2000).
    OpenUrlAbstract/FREE Full Text
  90. 90.↵
    1. A. A. Alibhoy,
    2. H. L. Chiang
    , Vacuole import and degradation pathway: Insights into a specialized autophagy pathway. World J. Biol. Chem. 2, 239–245 (2011).
    OpenUrlCrossRefPubMed
  91. 91.↵
    1. A. A. Alibhoy,
    2. B. J. Giardina,
    3. D. D. Dunton,
    4. H. L. Chiang
    , Vps34p is required for the decline of extracellular fructose-1,6-bisphosphatase in the vacuole import and degradation pathway. J. Biol. Chem. 287, 33080–33093 (2012).
    OpenUrlAbstract/FREE Full Text
  92. 92.↵
    1. A. A. Alibhoy,
    2. B. J. Giardina,
    3. D. D. Dunton,
    4. H. L. Chiang
    , Vid30 is required for the association of Vid vesicles and actin patches in the vacuole import and degradation pathway. Autophagy 8, 29–46 (2012).
    OpenUrlCrossRefPubMed
  93. 93.↵
    1. H. L. Chiang,
    2. R. Schekman
    , Regulated import and degradation of a cytosolic protein in the yeast vacuole. Nature 350, 313–318 (1991).
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. B. J. Giardina,
    2. B. A. Stanley,
    3. H. L. Chiang
    , Comparative proteomic analysis of transition of Saccharomyces cerevisiae from glucose-deficient medium to glucose-rich medium. Proteome Sci. 10, 40 (2012).
    OpenUrlCrossRefPubMed
  95. 95.↵
    1. M. Hoffman,
    2. H. L. Chiang
    , Isolation of degradation-deficient mutants defective in the targeting of fructose-1,6-bisphosphatase into the vacuole for degradation in Saccharomyces cerevisiae. Genetics 143, 1555–1566 (1996).
    OpenUrlAbstract/FREE Full Text
  96. 96.↵
    1. H. Liu,
    2. T. Pfirrmann
    , The gid-complex: An emerging player in the ubiquitin ligase league. Biol. Chem. 400, 1429–1441 (2019).
    OpenUrl
  97. 97.↵
    1. R. Menssen,
    2. K. Bui,
    3. D. H. Wolf
    , Regulation of the Gid ubiquitin ligase recognition subunit Gid4. FEBS Lett. 592, 3286–3294 (2018).
    OpenUrl
  98. 98.↵
    1. B. J. Giardina,
    2. H. L. Chiang
    , Fructose-1,6-bisphosphatase, malate dehydrogenase, isocitrate lyase, phosphoenolpyruvate carboxykinase, glyceraldehyde-3-phosphate dehydrogenase, and cyclophilin A are secreted in Saccharomyces cerevisiae grown in low glucose. Commun. Integr. Biol. 6, e27216 (2013).
    OpenUrlCrossRefPubMed
  99. 99.↵
    1. P. H. Huang,
    2. H. L. Chiang
    , Identification of novel vesicles in the cytosol to vacuole protein degradation pathway. J. Cell Biol. 136, 803–810 (1997).
    OpenUrlAbstract/FREE Full Text
  100. 100.↵
    1. H. L. Shieh,
    2. Y. Chen,
    3. C. R. Brown,
    4. H. L. Chiang
    , Biochemical analysis of fructose-1,6-bisphosphatase import into vacuole import and degradation vesicles reveals a role for UBC1 in vesicle biogenesis. J. Biol. Chem. 276, 10398–10406 (2001).
    OpenUrlAbstract/FREE Full Text
  101. 101.↵
    1. M. C. Chiang,
    2. H. L. Chiang
    , Vid24p, a novel protein localized to the fructose-1, 6-bisphosphatase-containing vesicles, regulates targeting of fructose-1,6-bisphosphatase from the vesicles to the vacuole for degradation. J. Cell Biol. 140, 1347–1356 (1998).
    OpenUrlAbstract/FREE Full Text
  102. 102.↵
    1. N. Kobayashi et al.
    , RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene 396, 236–247 (2007).
    OpenUrlCrossRefPubMed
  103. 103.↵
    1. O. Francis,
    2. F. Han,
    3. J. C. Adams
    , Molecular phylogeny of a RING E3 ubiquitin ligase, conserved in eukaryotic cells and dominated by homologous components, the muskelin/RanBPM/CTLH complex. PLoS One 8, e75217 (2013).
    OpenUrlCrossRefPubMed
  104. 104.↵
    1. T. Pfirrmann et al.
    , RMND5 from Xenopus laevis is an E3 ubiquitin-ligase and functions in early embryonic forebrain development. PLoS One 10, e0120342 (2015).
    OpenUrlCrossRefPubMed
  105. 105.↵
    1. F. Lampert et al.
    , The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation. eLife 7, e35528 (2018).
    OpenUrl
  106. 106.↵
    1. Y. Chang et al.
    , RanBPM regulates the progression of neuronal precursors through M-phase at the surface of the neocortical ventricular zone. Dev. Neurobiol. 70, 1–15 (2010).
    OpenUrlCrossRefPubMed
  107. 107.↵
    1. X. Jin et al.
    , MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation. Oncogenesis 6, e312 (2017).
    OpenUrl
  108. 108.↵
    1. L. C. Leal-Esteban,
    2. B. Rothé,
    3. S. Fortier,
    4. M. Isenschmid,
    5. D. B. Constam
    , Role of Bicaudal C1 in renal gluconeogenesis and its novel interaction with the CTLH complex. PLoS Genet. 14, e1007487 (2018).
    OpenUrl
  109. 109.↵
    1. M. E. R. Maitland et al.
    , The mammalian CTLH complex is an E3 ubiquitin ligase that targets its subunit muskelin for degradation. Sci. Rep. 9, 9864 (2019).
    OpenUrlCrossRefPubMed
  110. 110.↵
    1. C. J. McTavish et al.
    , Regulation of c-raf stability through the CTLH complex. Int. J. Mol. Sci. 20, E934 (2019).
    OpenUrl
  111. 111.↵
    1. A. Varshavsky
    , “Spalog” and “sequelog”: Neutral terms for spatial and sequence similarity. Curr. Biol. 14, R181–R183 (2004).
    OpenUrlCrossRefPubMed
  112. 112.↵
    1. Q. Xiao,
    2. F. Zhang,
    3. B. A. Nacev,
    4. J. O. Liu,
    5. D. Pei
    , Protein N-terminal processing: Substrate specificity of Escherichia coli and human methionine aminopeptidases. Biochemistry 49, 5588–5599 (2010).
    OpenUrlCrossRefPubMed
  113. 113.↵
    1. A. Varshavsky
    , Ubiquitin fusion technique and related methods. Methods Enzymol. 399, 777–799 (2005).
    OpenUrlCrossRefPubMed
  114. 114.↵
    1. F. M. Ausubel et al.
    , Current Protocols in Molecular Biology, (Wiley-Interscience, New York, 2017).
  115. 115.↵
    1. B. Andrews,
    2. C. Boone,
    3. T. N. Davis,
    4. S. Fields
    , Budding Yeast (A Laboratory Manual), (Cold Spring Harbor Press, Cold Spring Harbor, NY, 2016).
  116. 116.↵
    1. W. Kabsch
    , XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
    OpenUrlCrossRefPubMed
  117. 117.↵
    1. P. R. Evans,
    2. G. N. Murshudov
    , How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013).
    OpenUrlCrossRefPubMed
  118. 118.↵
    1. A. J. McCoy et al.
    , Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007).
    OpenUrlCrossRefPubMed
  119. 119.↵
    1. G. N. Murshudov et al.
    , REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355–367 (2011).
    OpenUrlCrossRefPubMed
  120. 120.↵
    1. P. Emsley,
    2. B. Lohkamp,
    3. W. G. Scott,
    4. K. Cowtan
    , Features and development of coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
    OpenUrlCrossRefPubMed
  121. 121.↵
    1. R. Frank
    , The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports—principles and applications. J. Immunol. Methods 267, 13–26 (2002).
    OpenUrlCrossRefPubMed
  122. 122.↵
    1. C. Dong et al
    ., GID4 in complex with IGLWKS peptide. Protein Data Bank, https://www.rcsb.org/structure/6WZX (Deposited 13 May 2020).
  123. 123.↵
    1. C. Dong et al
    ., GID4 in complex with VGLWKS peptide. Protein Data Bank, https://www.rcsb.org/structure/6WZZ (Deposited 13 May 2020).
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recognition of nonproline N-terminal residues by the Pro/N-degron pathway
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recognition of nonproline N-terminal residues by the Pro/N-degron pathway
Cheng Dong, Shun-Jia Chen, Artem Melnykov, Sara Weirich, Kelly Sun, Albert Jeltsch, Alexander Varshavsky, Jinrong Min
Proceedings of the National Academy of Sciences Jun 2020, 117 (25) 14158-14167; DOI: 10.1073/pnas.2007085117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Recognition of nonproline N-terminal residues by the Pro/N-degron pathway
Cheng Dong, Shun-Jia Chen, Artem Melnykov, Sara Weirich, Kelly Sun, Albert Jeltsch, Alexander Varshavsky, Jinrong Min
Proceedings of the National Academy of Sciences Jun 2020, 117 (25) 14158-14167; DOI: 10.1073/pnas.2007085117
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 117 (25)
Table of Contents

Submit

Sign up for Article Alerts

Article Classifications

  • Biological Sciences
  • Biochemistry

Jump to section

  • Article
    • Abstract
    • Results and Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Large piece of gold
News Feature: Tracing gold's cosmic origins
Astronomers thought they’d finally figured out where gold and other heavy elements in the universe came from. In light of recent results, they’re not so sure.
Image credit: Science Source/Tom McHugh.
Dancers in red dresses
Journal Club: Friends appear to share patterns of brain activity
Researchers are still trying to understand what causes this strong correlation between neural and social networks.
Image credit: Shutterstock/Yeongsik Im.
Yellow emoticons
Learning the language of facial expressions
Aleix Martinez explains why facial expressions often are not accurate indicators of emotion.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490